Preparative protein refolding

Trends in Biotechnology

Volumn 20, Issue 10, 2002, Pages 437-443

  Middelberg, Anton P J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG PRODUCTS; ESCHERICHIA COLI; PROTEINS;

CELLULAR BIOFACTORY;

BIOTECHNOLOGY;

BETA LACTAMASE; LIPOPOLYSACCHARIDE; NUCLEIC ACID; PHOSPHOLIPID; PLASMID DNA; POLYPEPTIDE; PROTEIN;

BIOTECHNOLOGY;

ANALYTIC METHOD; AUTOMATION; CIRCULAR DICHROISM; DILUTION; FLUORESCENCE; IMMUNOASSAY; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DENATURATION; PROTEIN FOLDING; PROTEIN PURIFICATION; PROTEIN RENATURATION; PROTEIN STRUCTURE; REVIEW; SPECTROPHOTOMETER;

CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, GEL; ESCHERICHIA COLI; INCLUSION BODIES; PROTEIN ARRAY ANALYSIS; PROTEIN BIOSYNTHESIS; PROTEIN FOLDING; PROTEINS; QUALITY CONTROL;

ESCHERICHIA COLI;

EID: 0036772580     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-7799(02)02047-4     Document Type: Review

References (43)

1. Carrió M.M., Villaverde A. Construction and deconstruction of bacterial inclusion bodies. J. Biotechnol. 96:2002;3-12.
2. Rudolph R., Lilie H. In vitro folding of inclusion body proteins. FASEB J. 10:1996;49-56.
3. Middelberg A.P.J. Process-scale disruption of microorganisms. Biotechnol. Adv. 13:1995;491-551.
4. Valax P., Georgiou G. Molecular characterization of beta-lactamase inclusion-bodies produced in Escherichia coli. 1. Composition. Biotechnol. Prog. 9:1993;539-547.
5. Maachupalli-Reddy J., et al. Effect of inclusion body contaminants on the oxidative renaturation of hen egg white lysozyme. Biotechnol. Prog. 13:1997;144-150.
6. Tran-Moseman A., et al. Renaturation of Escherichia coli-derived recombinant human macrophage colony-stimulating factor. Protein Expr. Purif. 16:1999;181-189.
7. Babbitt P.C., et al. Removal of a proteolytic activity associated with aggregates from expression of creatine-kinase in Escherichia coli leads to improved recovery of active enzyme. Biotechnology. 8:1990;945-949.
8. Wong H.H., et al. Centrifugal recovery and dissolution of recombinant Gly-IGF-II inclusion bodies: the impact of feedrate and re-centrifugation on protein yield. Bioseparation. 6:1996;185-192.
9. Geourgiou G., Valax P. Isolating inclusion bodies from bacteria. Methods Enzymol. 309:1999;48-58.
10. Wong H.H., et al. Cumulative sedimentation analysis of Escherichia coli debris size. Biotechnol. Bioeng. 55:1997;556-564.
11. Fischer B., et al. Isolation, renaturation, and formation of disulfide bonds of eukaryotic proteins expressed in Escherichia coli as inclusion bodies. Biotechnol. Bioeng. 41:1993;3-13.
12. Clark E.D., et al. Inhibition of aggregation side reactions during in vitro protein folding. Methods Enzymol. 309:1999;217-236.
13. Vuillard L., et al. Interactions of non detergent sulfobetaines with early folding intermediates facilitate in vitro protein renaturation. Eur. J. Biochem. 256:1998;128-135.
14. Puri N.K., Cardamone M. A relationship between the starting secondary structure of recombinant porcine growth hormone solubilized from inclusion bodies and the yield of native (monomeric) protein after in vitro refolding. FEBS Lett. 305:1992;177-180.
15. Hart R.A., et al. Large-scale, in situ isolation of periplasmic IGF-I from E. coli. Biotechnology. 12:1994;1113-1117.
16. Falconer R.J., et al. Chemical treatment of Escherichia coli. 2. Direct extraction of recombinant protein from cytoplasmic inclusion bodies in intact cells. Biotechnol. Bioeng. 57:1998;381-386.
17. Choe W-S., et al. Comparison of histidine-tag capture chemistries for purification following chemical extraction. J. Chromatogr. A. 953:2002;111-121.
18. Choe W-S., Middelberg A.P.J. Selective precipitation of DNA by spermine during the chemical extraction of insoluble cytoplasmic protein. Biotechnol. Prog. 17:2001;1107-1113.
19. Kiefhaber T., et al. Protein aggregation in vitro and in vivo: A quantitative model of the kinetic competition between folding and aggregation. Biotechnology. 9:1991;825-829.
20. Kotlarski N., et al. Optimal reactor selection for refolding monomeric protein. AIChE J. 43:1997;2123-2132.
21. Rudolph R., Fischer S. Process for obtaining renatured proteins. US Patent, 933. 4:1990;434.
22. Yasuda M., et al. Effect of additives on refolding of a denatured protein. Biotechnol. Prog. 14:1998;601-606.
23. Cleland J.L., Wang D.I.C. Cosolvent effects on refolding and aggregation. ACS Symposium Ser. 516:1993;151-166.
24. Hofmann A., et al. A sparse-matrix screen to establish initial conditions for protein renaturation. Anal. Biochem. 230:1995;8-15.
25. Tobbell D.A., et al. Identification of in vitro folding conditions for procathepsin S and cathepsin S using fractional factorial screens. Protein Expres. Purif. 24:2002;242-254.
26. Armstrong N., et al. A new protein folding screen: Application to the ligand binding domains of a glutamate and kainite receptor and to lysozyme and carbonic anhydrase. Protein Sci. 8:1999;1475-1483.
27. Xie Y.S., et al. Recombinant human retinol-binding protein refolding, native disulfide formation, and characterisation. Protein Expres. Purif. 14:1998;31-37.
28. Creighton, T.E. (1986) Folding of proteins adsorbed reversibly to ion-exchange resins. Protein Struct. Fold. Des. 249-257
29. Stempfer G., et al. Improved refolding of an immobilised fusion protein. Nat. Biotechnol. 14:1996;329-334.
30. Rogl H., et al. Refolding of Escherichia coli produced membrane protein inclusion bodies immobilised by nickel chelating chromatography. FEBS Lett. 432:1998;21-26.
31. Zahn R., et al. Human prion proteins expressed in Escherichia coli and purified by high affinity column refolding. FEBS Lett. 417:1997;400-404.
32. Berdichevsky Y., et al. Matrix-assisted refolding of single-chain Fv-cellulose binding domain fusion proteins. Protein Expres. Purif. 17:1999;249-259.
33. Werner M.H., et al. Refolding proteins by gel filtration chromatography. FEBS Lett. 345:1994;125-130.
34. Batas B., Chaudhuri J.B. Protein refolding at high concentration using size-exclusion chromatography. Biotechnol. Bioeng. 50:1996;16-23.
35. Gu Z., et al. Urea gradient size-exclusion chromatography enhanced the yield of lysozyme refolding. J. Chromatogr. A. 918:2001;311-318.
36. Altamirano M.M., et al. Oxidative refolding chromatography: folding of the scorpion toxin Cn5. Nat. Biotechnol. 17:1999;187-191.
37. Altamirano M.M., et al. Ligand-independent assembly of recombinant human CD1 by using oxidative refolding chromatography. Proc. Natl. Acad. Sci. U. S. A. 98:2001;3288-3293.
38. Heiring C., Muller Y.A. Folding screening assayed by proteolysis: application to various cystine deletion mutants of vascular endothelial growth factor. Protein Eng. 14:2001;183-188.
39. Wen J., et al. Size-exclusion chromatography with on-line light-scattering, absorbance, and refractive index detectors for studying proteins and their interactions. Anal. Biochem. 240:1996;155-166.
40. Nominé Y., et al. A strategy for optimizing the monodispersity fusion proteins: Application to purification of recombinant HPV E6 oncoprotein. Protein Eng. 14:2001;297-305.
41. Jensen P.K., et al. Monitoring protein refolding induced by disulfide formation using capillary isoelectric focusing electrospray ionization mass spectrometry. Anal. Chem. 70:1998;2044-2049.
42. Balbach J., et al. Following protein-folding in real-time using NMR-spectroscopy. Nat. Struct. Biol. 2:1995;865-870.
43. Navea S., et al. Three-way data analysis applied to multi-spectroscopic monitoring of protein folding. Anal. Chim. Acta. 446:2001;187-197.